Switching to letrozole or exemestane improves hot flushes, mood and quality of life in tamoxifen intolerant women
2008

Switching to letrozole or exemestane improves hot flushes, mood and quality of life in tamoxifen intolerant women

Sample size: 184 publication Evidence: high

Author Information

Author(s): Thomas R, Williams M, Marshall C, Walker L

Primary Institution: Primrose Oncology Research Unit, Bedford Hospital NHS Trust

Hypothesis

Does switching from tamoxifen to an aromatase inhibitor improve quality of life for women experiencing hot flushes?

Conclusion

Switching to letrozole or exemestane significantly improves hot flushes, mood, and quality of life in women who are intolerant to tamoxifen.

Supporting Evidence

  • Hot flush scores improved by 47.3% after switching to an AI.
  • Mood ratings improved by 9.7% after switching.
  • Quality of life scores increased significantly after switching treatments.

Takeaway

If women taking tamoxifen feel really uncomfortable, switching to a different medicine can help them feel better and happier.

Methodology

An open-label, prospective, crossover study involving 184 post-menopausal women experiencing hot flushes on tamoxifen.

Potential Biases

Potential physician bias and influence from media reports on treatment preferences.

Limitations

The study design was open-label, which may introduce bias.

Participant Demographics

Post-menopausal women with a mean age of 58.8 years, experiencing hot flushes on tamoxifen.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI ±2.96

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1038/sj.bjc.6604323

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication